Camp RL - Search Results

1

Genetic differentiation of appendiceal tumor malignancy: a guide for the perplexed.

Modlin IM, Kidd M, Latich I, Zikusoka MN, Eick GN, Mane SM, Camp RL. Modlin IM, et al. Among authors: camp rl. Ann Surg. 2006 Jul;244(1):52-60. doi: 10.1097/01.sla.0000217617.06782.d5. Ann Surg. 2006. PMID: 16794389 Free PMC article.

2

Small bowel carcinoid (enterochromaffin cell) neoplasia exhibits transforming growth factor-beta1-mediated regulatory abnormalities including up-regulation of C-Myc and MTA1.

Kidd M, Modlin IM, Pfragner R, Eick GN, Champaneria MC, Chan AK, Camp RL, Mane SM. Kidd M, et al. Among authors: camp rl. Cancer. 2007 Jun 15;109(12):2420-31. doi: 10.1002/cncr.22725. Cancer. 2007. PMID: 17469181 Free article.

3

The role of genetic markers--NAP1L1, MAGE-D2, and MTA1--in defining small-intestinal carcinoid neoplasia.

Kidd M, Modlin IM, Mane SM, Camp RL, Eick G, Latich I. Kidd M, et al. Among authors: camp rl. Ann Surg Oncol. 2006 Feb;13(2):253-62. doi: 10.1245/ASO.2006.12.011. Epub 2006 Jan 20. Ann Surg Oncol. 2006. PMID: 16424981

4

Q RT-PCR detection of chromogranin A: a new standard in the identification of neuroendocrine tumor disease.

Kidd M, Modlin IM, Mane SM, Camp RL, Shapiro MD. Kidd M, et al. Among authors: camp rl. Ann Surg. 2006 Feb;243(2):273-80. doi: 10.1097/01.sla.0000197734.28551.0f. Ann Surg. 2006. PMID: 16432362 Free PMC article.

5

Utility of molecular genetic signatures in the delineation of gastric neoplasia.

Kidd M, Modlin IM, Mane SM, Camp RL, Eick GN, Latich I, Zikusoka MN. Kidd M, et al. Among authors: camp rl. Cancer. 2006 Apr 1;106(7):1480-8. doi: 10.1002/cncr.21758. Cancer. 2006. PMID: 16502410 Free article.

6

Predicting neuroendocrine tumor (carcinoid) neoplasia using gene expression profiling and supervised machine learning.

Drozdov I, Kidd M, Nadler B, Camp RL, Mane SM, Hauso O, Gustafsson BI, Modlin IM. Drozdov I, et al. Among authors: camp rl. Cancer. 2009 Apr 15;115(8):1638-50. doi: 10.1002/cncr.24180. Cancer. 2009. PMID: 19197975 Free PMC article.

7

Microsatellite instability and gene mutations in transforming growth factor-beta type II receptor are absent in small bowel carcinoid tumors.

Kidd M, Eick G, Shapiro MD, Camp RL, Mane SM, Modlin IM. Kidd M, et al. Among authors: camp rl. Cancer. 2005 Jan 15;103(2):229-36. doi: 10.1002/cncr.20750. Cancer. 2005. PMID: 15599934 Free article.

8

HSP90 as a marker of progression in melanoma.

McCarthy MM, Pick E, Kluger Y, Gould-Rothberg B, Lazova R, Camp RL, Rimm DL, Kluger HM. McCarthy MM, et al. Among authors: camp rl. Ann Oncol. 2008 Mar;19(3):590-4. doi: 10.1093/annonc/mdm545. Epub 2007 Nov 23. Ann Oncol. 2008. PMID: 18037622 Free article.

9

Automated quantitative analysis of HDM2 expression in malignant melanoma shows association with early-stage disease and improved outcome.

Berger AJ, Camp RL, Divito KA, Kluger HM, Halaban R, Rimm DL. Berger AJ, et al. Among authors: camp rl. Cancer Res. 2004 Dec 1;64(23):8767-72. doi: 10.1158/0008-5472.CAN-04-1384. Cancer Res. 2004. PMID: 15574789

10

Using a xenograft model of human breast cancer metastasis to find genes associated with clinically aggressive disease.

Kluger HM, Chelouche Lev D, Kluger Y, McCarthy MM, Kiriakova G, Camp RL, Rimm DL, Price JE. Kluger HM, et al. Among authors: camp rl. Cancer Res. 2005 Jul 1;65(13):5578-87. doi: 10.1158/0008-5472.CAN-05-0108. Cancer Res. 2005. PMID: 15994930

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

124 results

Search Page